|
Makashova V.V., Omarova Zh.G., Ponezheva ZH.B., Ivashkova T.A., Gorelov A.V.
Chronic hepatitis C and its outcomes: liver cirrhosis, hepatocellular carcinoma
|
№1 / 2023
|
|
Saranskaya Ya.E., Kiseleva L.M., Sachek A.A.
Regression of liver fibrosis in patients with chronic hepatitis C after a cycle of therapy with direct-acting antivirals
|
№1 / 2023
|
|
Ponezheva Zh.B., Akimkin V.G., Mannanova I.V., Ugleva S.V., Duganova S.E., Shabalina S.V.
Relationship between immunological parameters and the severity of liver fibrosis in patients with chronic hepatitis C
|
№1 / 2023
|
|
Nikolaeva L.I., Shevchenko N.G., Dedova A.V., Sapronov G.V., Samokhvalov E.I., Vakhromeev A.A.
Comparative analysis of specific and non-specific markers in patients with different stages of liver fibrosis in chronic hepatitis C
|
№4 / 2022
|
|
Volkova S.B., Podymova A.S.
Demographic and clinical characteristics of patients with new-onset HIV/CHC coinfection with the known HCV genotype
|
№1 / 2022
|
|
Churbakova O.V., Akimkin V.G., Pechkurov D.V.
A rational approach to choosing a treatment option for chronic hepatitis C using a prognostic model in children and adolescents
|
№4 / 2020
|
|
Ponezheva Zh.B., Makashova V.V., Sannikova I.V., Titorenko M.V., Mannanova I.V., Patlusov E.V., Kambieva L.F., Ivanova M.R.
Experience with narlaprevir in the treatment of chronic hepatitis C
|
№2 / 2020
|
|
Grushko I.P., Romanova E.B., Tverdokhlebova T.I.
The role of endothelial dysfunction in the pathogenesis of chronic hepatitis C and methods of its correction
|
№2 / 2020
|
|
Orlova S.N., Baskhanova M.V.
Efficiency of antiviral therapy for chronic hepatitis c in patients with undifferentiated connective tissue dysplasia
|
№2 / 2019
|
|
Ginyatullin R.R., Kitaev M.R., Vafin A.Yu., Kravchenko I.E.
A follow-up of patients with HCV-infection markers in the rural infectious diseases room of a rural area
|
№2 / 2018
|
|
Orlova S.N., Baskhanova M.V.
The natural course of chronic hepatitis C in patients with undifferentiated connective tissue dysplasia
|
№5 / 2017
|
|
Khaertynova I.M., Sozinova Yu.M., Galeeva N.V., Gaifullina E.G., Urmancheeva Yu.R., Gataullin M.R.
Experience of treatment with direct-acting antiviral drugs in patients with cirrhosis at the outcome of chronic hepatitis
|
№2 / 2017
|
Русский
